Literature DB >> 24238966

Schizophrenia and antipsychotic medication--better adherence, better outcomes?

A B P Staring1, M Van der Gaag, C L Mulder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24238966     DOI： 10.1016/j.schres.2013.10.035

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  4 in total

1.  Optimal sampling of antipsychotic medicines: a pharmacometric approach for clinical practice.

Authors:  Vidya Perera; Robert R Bies; Gary Mo; Michael J Dolton; Vaughan J Carr; Andrew J McLachlan; Richard O Day; Thomas M Polasek; Alan Forrest
Journal:  Br J Clin Pharmacol       Date:  2014-10       Impact factor: 4.335

2.  Money for medication: a randomized controlled study on the effectiveness of financial incentives to improve medication adherence in patients with psychotic disorders.

Authors:  Ernst L Noordraven; Charlotte H Audier; Anton B P Staring; Andre I Wierdsma; Peter Blanken; Bas E A van der Hoorn; Leona Hakkaart-van Roijen; Cornelis L Mulder
Journal:  BMC Psychiatry       Date:  2014-12-02       Impact factor: 3.630

3.  Psychometric evaluation of personal evaluation of transitions in treatment amongst patients with schizophrenia.

Authors:  Oladipo A Sowunmi; Peter O Onifade; Oluwatoyin R Sowunmi
Journal:  S Afr J Psychiatr       Date:  2021-03-05       Impact factor: 1.550

4.  Ethical acceptability of offering financial incentives for taking antipsychotic depot medication: patients' and clinicians' perspectives after a 12-month randomized controlled trial.

Authors:  Ernst L Noordraven; Maartje H N Schermer; Peter Blanken; Cornelis L Mulder; André I Wierdsma
Journal:  BMC Psychiatry       Date:  2017-08-29       Impact factor: 3.630
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.